Beyond CRISPR: Exploring Next-Generation Gene Editing with TARGATT, Mad7, and Base Editing | ASC

Speaker: Ruby Tsai, Ph.D.,
CEO, Founder, and President @ Applied StemCell
🔗 https://www.appliedstemcell.com/
5/22 10:00 AM PST
25 min + 10 min FAQ

This webinar is designed for researchers, scientists, biotech executives, business development, and IP professionals working in the fields of gene editing, biotechnology, and therapeutic development who are interested in expanding their knowledge of advanced gene editing technologies beyond CRISPR.

Join us to delve into the forefront of gene editing with Applied StemCell's pioneering technologies: TARGATT, Mad7, and Base Editing. Explore how these innovative tools are transforming the fields of genetic engineering and biomedicine. Plus, uncover key insights into the technology overview, IP landscape, and comparative analysis, offering a holistic understanding of these revolutionary gene editing solutions.

TARGATT: Delve into the TARGATT system, a cutting-edge site-specific knock-in technology renowned for its precise targeting and stable integration of transgenes into the host genome. Learn about its unique mechanism, diverse applications, and advantages over conventional gene editing methods. Explore its relevance in allogenic approaches, GMP iPSC, high-throughput library, and bioproduction.

Mad7: Unveil the potential of Mad7 in its applications in therapeutic gene editing.

Base Editing: Immerse yourself in this revolutionary technology enabling the direct conversion of one DNA base pair to another with no detectable off-target events.

Don't miss this opportunity to stay ahead of the curve and learn about the future of gene editing and their applications with Applied StemCell's innovative technology webinar series.